Chinook Therapeutics, Inc. Company Profile

01:28 EST 23rd January 2020 | BioPortfolio

Chinook Therapeutics, Inc. is a clinical-stage biotechnology company developing precision medicines for kidney diseases. The company’s pipeline is focused on rare, severe kidney disorders with defined and rapid clinical pathways. Chinook’s lead program is atrasentan, an endothelin receptor antagonist planned for development for primary glomerular diseases. The company is also advancing research programs for an undisclosed ultra orphan kidney disease and polycystic kidney disease. Chinook is building its pipeline by leveraging novel insights in kidney single cell RNA sequencing, human-derived organoids and new translational models, to discover and develop therapeutics with novel mechanisms of action against key kidney disease pathways. Chinook is backed by leading global healthcare investors, Versant Ventures, Apple Tree Partners, and Samsara BioCapital, and is based in Vancouver, BC and Seattle, WA. For more information visit

News Articles [779 Associated News Articles listed on BioPortfolio]

Financing round brings in $65M for Chinook Therapeutics

Canadian biotech firm Chinook Therapeutics gained $65 million through a Series A financing round that it will use to develop  -More- 

Chinook secures funds for kidney disease treatments

Canada-based Chinook Therapeutics has received funds in a Series A round to support the development of precision medicines for treating...Read More... The post Chinook secures funds for kidney disease...

Series A brings in $65mm for kidney disease-focused Chinook Therapeutics

Chinook Therapeutics Inc. (precision medicines for kidney diseases) raised $65mm through its Series A round. Founding investor Versant Ventures led and was joined by co-founder Apple Tree Partners and...

New BC Biotech Chinook Reels in $65M to Tackle Kidney Disease

About 15 percent of adults in the US, or around 37 million people, are estimated to have chronic kidney disease, according to the Centers for Disease Control. There are very few therapeutic options fo...

Resident orcas’ appetite likely reason for decline of big Chinook salmon

Killer whales prefer to eat only the biggest, juiciest Chinook salmon they can find. The larger the fish, the more energy a whale can get for its meal. Each year these top ocean predators consume more...

With $65 Million in Hand, Chinook Therapeutics Launches to Tackle Kidney Disease

The new company, which was founded earlier this year, will take a similar approach to treat kidney disease that oncologists have taken with cancer.

Chinook Therapeutics Obtains Worldwide Rights from AbbVie to Atrasentan with Plans to Develop for the Treatment of Kidney Diseases

Chinook Therapeutics, Inc., a biotechnology company focused on developing precision medicines for kidney diseases, today announced it has entered into a license agreement with AbbVie, a research-base...

Eyeing new endpoints, Versant-backed Chinook reels in $65M series A for kidney therapies

Drugs and Medications [27 Associated Drugs and Medications listed on BioPortfolio]

Kynamro [kastle therapeutics, llc]


Olopatadine hydrochloride [somerset therapeutics, llc]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

Oxygen [breathe easy therapeutics, inc]


Diclofenac sodium delayed release [cambridge therapeutics technologies, llc]

Diclofenac Sodium

Olopatadine hydrochloride [a-s medication solutions]

OLOPATADINE Hydrochloride Ophthalmic Solution USP, 0.1%Somerset Therapeutics, LLC

PubMed Articles [423 Associated PubMed Articles listed on BioPortfolio]

In vitro immune response of chinook salmon (Oncorhynchus tshawytscha) peripheral blood mononuclear cells stimulated by bacterial lipopolysaccharide.

We investigated cellular functional and targeted immune cytokine responses of farmed Chinook salmon (Oncorhynchus tshawytscha) peripheral blood mononuclear cells (PBMCs) in vitro to LPS from Escherich...

Digital Therapeutics: Emerging New Therapy for Neurologic Deficits after Stroke.

Digital therapeutics is an evidence-based intervention using high-quality software, with the sole purpose of treatment. As many healthcare systems are encountering high demands of quality outcomes, th...

Measurement of mRNA therapeutics: method development and validation challenges.

The progression of chemically modified mRNA therapeutics through development pipelines is accelerating for many disease indications and the need to assess these analytes is becoming more routine for t...

Dr E. Keith Borden: Inaugural President of the Canadian Association for Population Therapeutics.

Pharmacovigilance 2030: Invited Commentary for the January 2020 "Futures" Edition of Clinical Pharmacology and Therapeutics.

Clinical Trials [206 Associated Clinical Trials listed on BioPortfolio]

Long-term Follow-Up Study Following Treatment With Fate Therapeutics' Engineered Cellular Immunotherapy

The purpose of the study is to assess long-term side effects from subjects who receive a Fate Therapeutics genetically modified NK cell product. Subjects who previously took part in a Fate...

Impact of Ibis on Patients With Advanced COPD

The purpose of this research is to determine if Ibis™, a digital therapeutics solution developed by Senscio Systems, reduces the emergency room visits and hospitalizations of patients wi...

HDL Acute Lipid Optimization in Homozygous Familial Hypercholesterolemia

Assess the effect on coronary atheroma of serial infusions of autologous selectively delipidated HDL/preβ enriched plasma following use of HDL Therapeutics PDS-2™ System

Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatic (CHINOOK)

The purpose of the study is to evaluate effect of benralizumab on structural and lung function changes in severe eosinophilic asthmatics. Changes will be assessed over 48 week treatment p...

Ontogenesis of the P-Glycoprotein in Human Lymphocytes Influence of HIV and Antiretroviral Therapeutics

The P-glycoprotein (P-gp) is a membranous transporter that modulates the intracellular concentrations of many drugs and plays thus a major role in the efficacy of the therapeutics that act...

Companies [1416 Associated Companies listed on BioPortfolio]

Chinook Therapeutics, Inc.

Chinook Therapeutics, Inc. is a clinical-stage biotechnology company developing precision medicines for kidney diseases. The company’s pipeline is focused on rare, severe kidney disorders with d...

Chinook Book

Chinook Book is an annual resource guide and coupon book that promotes healthy, sustainable living in the Denver/Boulder community. From large, well-known establishments like Sunflower Farmers Market...

Aeris Therapeutics

Aeris Therapeutics is an emerging medical therapeutics company specializing in the development and commercialization of novel treatments for patients with emphysema and other adva...

Altair Therapeutics, Inc.

Based in San Diego, Altair Therapeutics, Inc. is a privately-held biopharmaceutical company developing novel therapeutics to treat human respiratory diseases. Altair Therap...

Vaxiion Therapeutics, Inc.

Vaxiion is dedicated to the design and development of intelligent drug-delivery technologies with special emphasis on targeted oncology therapeutics. Vaxiion Therapeutics was spun...

More Information about "Chinook Therapeutics, Inc." on BioPortfolio

We have published hundreds of Chinook Therapeutics, Inc. news stories on BioPortfolio along with dozens of Chinook Therapeutics, Inc. Clinical Trials and PubMed Articles about Chinook Therapeutics, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Chinook Therapeutics, Inc. Companies in our database. You can also find out about relevant Chinook Therapeutics, Inc. Drugs and Medications on this site too.

Quick Search

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Nephrology - kidney function
Nephrology is a specialty of medicine and pediatrics that concerns itself with the study of normal kidney function, kidney problems, the treatment of kidney problems and renal replacement therapy (dialysis and kidney transplantation). Systemic conditions...

Corporate Database Quicklinks

Searches Linking to this Company Record